Pfizer’s cancer drug crizotinib was able to shrink tumors of non-small-cell lung cancer patients whose tumors carried a specific genetic mutation that fuses two genes. The early-stage study results were published in the New England Journal of Medicine.
Continue reading Pfizer Makes Headway in the Fight Against Lung Cancer
Pfizer Makes Headway in the Fight Against Lung Cancer originally appeared on DailyFinance on Thu, 28 Oct 2010 17:30:00.
Filed Under: Company News, Health Care, Pfizer, Stocks in the News